Aviva PLC Sells 60,056 Shares of Colgate-Palmolive Company $CL

Aviva PLC lowered its position in Colgate-Palmolive Company (NYSE:CL) by 2.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,199,064 shares of the company’s stock after selling 60,056 shares during the quarter. Aviva PLC’s holdings in Colgate-Palmolive were worth $173,770,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. CBIZ Investment Advisory Services LLC increased its holdings in shares of Colgate-Palmolive by 86.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after purchasing an additional 150 shares during the period. Jessup Wealth Management Inc bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $26,000. Maseco LLP bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $27,000. Global Wealth Strategies & Associates increased its holdings in shares of Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares during the period. Finally, Grove Bank & Trust increased its holdings in shares of Colgate-Palmolive by 182.6% in the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after purchasing an additional 263 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.5%

Shares of NYSE:CL opened at $89.48 on Friday. The stock’s 50-day moving average price is $86.77 and its 200-day moving average price is $86.23. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The stock has a market capitalization of $71.60 billion, a P/E ratio of 34.82, a price-to-earnings-growth ratio of 4.74 and a beta of 0.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. During the same period last year, the firm earned $0.91 earnings per share. The company’s revenue for the quarter was up 8.4% compared to the same quarter last year. On average, equities analysts anticipate that Colgate-Palmolive Company will post 3.81 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Bank of America reduced their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a research note on Thursday. They issued a “market perform” rating and a $96.00 target price on the stock. Royal Bank Of Canada reissued an “outperform” rating and issued a $102.00 target price on shares of Colgate-Palmolive in a research note on Monday, May 4th. Barclays increased their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 5th. Finally, Rothschild & Co Redburn set a $100.00 target price on Colgate-Palmolive and gave the company a “buy” rating in a research note on Tuesday, April 21st. Twelve equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.